- Anxiety
- Depression
- Alzheimer's Disease
- Weight Loss
- Heart Disease
- Cancer
- Asthma
Trial Phase
Trial Status
Paid Participation
38 Obesity Trials near Pahrump, NV
Power is an online platform that helps thousands of Obesity patients discover FDA-reviewed trials every day. Every trial we feature meets safety and ethical standards, giving patients an easy way to discover promising new treatments in the research stage.
Learn More About PowerOrforglipron for Obesity
Trial Details
Key Eligibility Criteria
1500 Participants Needed
Orforglipron for Type 2 Diabetes and Obesity
Trial Details
Key Eligibility Criteria
2749 Participants Needed
Tirzepatide for Obesity
Trial Details
Key Eligibility Criteria
15374 Participants Needed
Retatrutide for Type 2 Diabetes and Obesity
Trial Details
Key Eligibility Criteria
1000 Participants Needed
Orforglipron for Obesity
Trial Details
Key Eligibility Criteria
3127 Participants Needed
LY3305677 for Obesity
Trial Details
Key Eligibility Criteria
1217 Participants Needed
Retatrutide for Obesity
Trial Details
Key Eligibility Criteria
2300 Participants Needed
Retatrutide for Obesity and Cardiovascular Disease
Trial Details
Key Eligibility Criteria
1800 Participants Needed
Semaglutide + Low-Dose Insulin Glargine for Type 2 Diabetes
Trial Details
Key Eligibility Criteria
568 Participants Needed
Retatrutide for Chronic Kidney Disease and Obesity
Trial Details
Key Eligibility Criteria
146 Participants Needed
Retatrutide for Obesity
Trial Details
Key Eligibility Criteria
10000 Participants Needed
Cagrilintide for Obesity and Type 2 Diabetes
Trial Details
Key Eligibility Criteria
330 Participants Needed
Tirzepatide for Type 1 Diabetes and Obesity
Trial Details
Key Eligibility Criteria
905 Participants Needed
Retatrutide for Obesity
Trial Details
Key Eligibility Criteria
643 Participants Needed
Maridebart Cafraglutide for Obesity
Trial Details
Key Eligibility Criteria
3853 Participants Needed
Orforglipron for Obesity
Trial Details
Key Eligibility Criteria
300 Participants Needed
GZR18 vs Tirzepatide for Obesity
Trial Details
Key Eligibility Criteria
285 Participants Needed
AZD6234 for Type 2 Diabetes and Obesity
Trial Details
Key Eligibility Criteria
64 Participants Needed
LY3549492 for Obesity
Trial Details
Key Eligibility Criteria
275 Participants Needed
LY3841136 + Tirzepatide for Obesity with Type 2 Diabetes
Trial Details
Key Eligibility Criteria
350 Participants Needed
Why Other Patients Applied
"I changed my diet in 2020 and I’ve lost 95 pounds from my highest weight (283). I am 5’3”, female, and now 188. I still have a 33 BMI. I've been doing research on alternative approaches to continue my progress, which brought me here to consider clinical trials."
"I am applying for my daughter. She turns 12 this year and is overweight. She's 5'4" and 176 pounds. Would be great to enroll her in a clinical trial to see if this form of care could work for her. Realize that there's no guarantee, but I support her and we'd like to give it a try."
"I have tried to lose weight, but as I get older, it becomes harder and harder. I have lost weight in the past through diet and exercise, but it has been more difficult to accomplish as I age."
"I need to lose weight because it's affecting my knees. I've already had a knee replacement and the second one is happening on the left knee in a few months. I've participated in a study in the past for a skin-related issue, and had a good experience. That's why I'm interested in joining a study for wieght loss."
"I have a heart condition, and my fat is all in my chest, surrounding my heart. It's hard for me to exercise because my legs are thin and the upper body weight is too much — putting strain on my leg joints. It’s a vicious cycle. I am also post-menopausal, which adds additional weight loss difficulty. I also have stress with being a full time caregiver for my mom. I'm interested in trying a clinical trial."
Nimacimab and Nimacimab + Semaglutide for Obesity
Trial Details
Key Eligibility Criteria
120 Participants Needed
LY3841136 for Obesity
Trial Details
Key Eligibility Criteria
263 Participants Needed
LY3305677 for Obesity
Trial Details
Key Eligibility Criteria
179 Participants Needed
Maridebart Cafraglutide for Cardiovascular Disease
Trial Details
Key Eligibility Criteria
12800 Participants Needed
Orforglipron for Obesity
Trial Details
1200 Participants Needed
Orforglipron for Type 2 Diabetes and Obesity
Trial Details
Key Eligibility Criteria
600 Participants Needed
Orforglipron for Obesity
Trial Details
Key Eligibility Criteria
600 Participants Needed
Macupatide + Eloralintide for Obesity
Trial Details
Key Eligibility Criteria
200 Participants Needed
Petrelintide for Obesity and Type 2 Diabetes
Trial Details
Key Eligibility Criteria
216 Participants Needed
Ixekizumab + Tirzepatide for Psoriasis
Trial Details
Key Eligibility Criteria
250 Participants Needed
Know someone looking for new options?
Spread the word
